Payment overview · 2025
General Payments
$133.60
2 reported records · 2 companies
Healthcare provider profile · identity verified
Neil Miller, MD
Allopathic & Osteopathic Physicians|Internal Medicine · THOMASTON, CT · NPI 1154370401
Verified facts
What the public records show
CMS Open Payments records show Neil Miller, MD received $133.60 in general payments during 2025 across 2 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 73.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $97.83 | 73.2% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $35.77 | 26.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $133.60 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $97.83 | 1 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $35.77 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 747 | 74 |
| Levothyroxine Sodium | Levothyroxine Sodium | 597 | 55 |
| Trazodone Hcl | Trazodone Hcl | 417 | 73 |
| Gabapentin | Gabapentin | 390 | 42 |
| Sertraline Hcl | Sertraline Hcl | 335 | 22 |
| Furosemide | Furosemide | 324 | 49 |
| Amlodipine Besylate | Amlodipine Besylate | 315 | 45 |
| Escitalopram Oxalate | Escitalopram Oxalate | 271 | 38 |
| Pantoprazole Sodium | Pantoprazole Sodium | 240 | 52 |
| Eliquis | Apixaban | 226 | 35 |
| Mirtazapine | Mirtazapine | 222 | 34 |
| Donepezil Hcl | Donepezil Hcl | 209 | 14 |
| Metoprolol Tartrate | Metoprolol Tartrate | 192 | 31 |
| Tamsulosin Hcl | Tamsulosin Hcl | 186 | 33 |
| Risperidone | Risperidone | 164 | 12 |
| Potassium Chloride | Potassium Chloride | 162 | 38 |
| Metoprolol Succinate | Metoprolol Succinate | 140 | 30 |
| Lisinopril | Lisinopril | 135 | 22 |
| Losartan Potassium | Losartan Potassium | 132 | 22 |
| Montelukast Sodium | Montelukast Sodium | 130 | 17 |
| Jardiance | Empagliflozin | 128 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 120 | 12 |
| Xarelto | Rivaroxaban | 120 | suppressed |
| Omeprazole | Omeprazole | 105 | 17 |
| Duloxetine Hcl | Duloxetine Hcl | 104 | 17 |
| Metformin Hcl | Metformin Hcl | 99 | 19 |
| Quetiapine Fumarate | Quetiapine Fumarate | 95 | 16 |
| Tradjenta | Linagliptin | 95 | suppressed |
| Simvastatin | Simvastatin | 91 | 12 |
| Allopurinol | Allopurinol | 90 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 87 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 85 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 85 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 83 | 12 |
| Torsemide | Torsemide | 83 | suppressed |
| Carvedilol | Carvedilol | 82 | 12 |
| Glimepiride | Glimepiride | 79 | suppressed |
| Linzess | Linaclotide | 77 | 11 |
| Finasteride | Finasteride | 73 | suppressed |
| Levetiracetam | Levetiracetam | 68 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 68 | 13 |
| Januvia | Sitagliptin Phosphate | 66 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 66 | suppressed |
| Baclofen | Baclofen | 62 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 62 | 15 |
| Midodrine Hcl | Midodrine Hcl | 60 | 12 |
| Nyamyc | Nystatin | 60 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 58 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 57 | 11 |
| Entresto | Sacubitril/Valsartan | 56 | suppressed |
| Memantine Hcl | Memantine Hcl | 56 | 12 |
| Citalopram Hbr | Citalopram Hydrobromide | 53 | 12 |
| Farxiga | Dapagliflozin Propanediol | 53 | suppressed |
| Prednisone | Prednisone | 53 | 25 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 51 | suppressed |
| Myrbetriq | Mirabegron | 51 | suppressed |
| Latanoprost | Latanoprost | 50 | suppressed |
| Olanzapine | Olanzapine | 50 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 49 | 27 |
| Diclofenac Sodium | Diclofenac Sodium | 44 | suppressed |
| Bupropion Xl | Bupropion Hcl | 43 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 43 | 14 |
| Valsartan | Valsartan | 43 | suppressed |
| Spironolactone | Spironolactone | 42 | suppressed |
| Famotidine | Famotidine | 41 | 11 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 39 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 38 | 19 |
| Aripiprazole | Aripiprazole | 38 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 37 | 36 |
| Doxycycline Hyclate | Doxycycline Hyclate | 37 | 16 |
| Ezetimibe | Ezetimibe | 37 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 36 | suppressed |
| Erythromycin | Erythromycin Base | 33 | suppressed |
| Rexulti | Brexpiprazole | 33 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 31 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 30 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 29 | 24 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 24 |
| Lactulose | Lactulose | 28 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 26 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 26 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 26 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 26 | suppressed |
| Lamotrigine | Lamotrigine | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 25 | suppressed |
| Lidocaine | Lidocaine | 24 | suppressed |
| Nystatin | Nystatin | 24 | 15 |
| Lovastatin | Lovastatin | 23 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 21 | 11 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 21 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 14 |
| Humalog | Insulin Lispro | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 19 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 18 | suppressed |
| Levofloxacin | Levofloxacin | 18 | 14 |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 18 | suppressed |
| Cephalexin | Cephalexin | 17 | 13 |
| Fluphenazine Hcl | Fluphenazine Hcl | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Methocarbamol | Methocarbamol | 17 | suppressed |
| Ranolazine Er | Ranolazine | 17 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 16 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 16 | 12 |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 16 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 16 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 16 | suppressed |
| Trulicity | Dulaglutide | 16 | suppressed |
| Enulose | Lactulose | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | suppressed |
| Rivastigmine | Rivastigmine | 15 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Methenamine Mandelate | Methenamine Mandelate | 14 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 14 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 13 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 11 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 13 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Cefadroxil | Cefadroxil | 12 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 12 | suppressed |
| Mirabegron Er | Mirabegron | 12 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Relistor | Methylnaltrexone Bromide | 12 | suppressed |
| Dutasteride | Dutasteride | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Ketoconazole | Ketoconazole | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $133.60 · 2 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR, INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error